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IMPORTANCE The need for improvedmethods of hemorrhage control and resuscitation has
resulted in a reappraisal of resuscitative endovascular balloon occlusion of the aorta (REBOA).
However, there is a paucity of data regarding the use of REBOA on amulti-institutional level
in the United States.
OBJECTIVE To evaluate the outcomes in trauma patients after REBOA placement.
DESIGN, SETTING, AND PARTICIPANTS A case-control retrospective analysis was performed of
the 2015-2016 American College of Surgeons Trauma Quality Improvement Program data set,
a national multi-institutional database of trauma patients in the United States. A total of
593 818 adult trauma patients (aged18 years) were analyzed and 420 patients were
matched and included in the study; patients who were dead on arrival or were transferred
from other facilities were excluded. Trauma patients who underwent REBOA placement in
the EDwere identified andmatched with a similar cohort of patients (the no-REBOA group).
Both groups were matched in a 1:2 ratio using propensity score matching for demographics,
vital signs, mechanism of injury, injury severity score, head abbreviated injury scale score,
each body region abbreviated injury scale score, pelvic fractures, lower extremity vascular
injuries and fractures, and number and grades of intra-abdominal solid organ injuries.
MAIN OUTCOMES ANDMEASURES Outcomemeasures were the rates of complications
andmortality.
RESULTS Of 593818 trauma patients, 420 patients (the REBOA group, 140 patients; 36women
and 104men;mean [SD] age, 44 [20] years; the no-REBOA group, 280 patients; 77women and
203men;mean [SD] age, 43 [19] years) werematched and included in the analysis. Among the
REBOA group,median injury severity scorewas 29 (interquartile range [IQR], 18-38) and 129
patients (92.1%) had a bluntmechanism of injury. Therewas no significant difference between
groups inmedian 4-hour blood transfusion (REBOA: packed red blood cells, 6 U [IQR, 3-8 U];
platelets, 4 U [IQR, 3-9 U], and plasma, 3 U [IQR, 2-5 U]; and no-REBOA: packed red blood cells,
7 U [IQR, 3-9 U]; platelets, 4 U [IQR, 3-8 U], and plasma, 3 U [IQR, 2-6 U]) or 24-hour blood
transfusion (REBOA: packed red blood cells, 9 U [IQR, 5-20U]; platelets, 7 U [IQR, 3-13 U], and
plasma, 9 U [IQR, 6-20U]; and no-REBOA: packed red blood cells, 10 U [IQR, 4-21 U]; platelets,
8 U [IQR, 3-12 U], and plasma, 10U [IQR, 7-20U]), median hospital length of stay (REBOA,
8 days [IQR, 1-20 days]; and no-REBOA, 10 days [IQR, 5-22 days]), ormedian intensive care
unit length of stay (REBOA, 5 days [IQR, 2-14 days]; and no-REBOA, 6 days [IQR, 3-15 days]).
Themortality ratewas higher in the REBOA group as comparedwith the no-REBOA group
(50 [35.7%] vs 53 [18.9%]; P = .01). Patients who underwent REBOAplacementwere also
more likely to develop acute kidney injury (15 [10.7%] vs 9 [3.2%]; P = .02) andmore likely to
undergo lower extremity amputation (5 [3.6%] vs 2 [0.7%]; P = .04).
CONCLUSIONS AND RELEVANCE Placement of REBOA in severely injured trauma patients
was associated with a higher mortality rate compared with a similar cohort of patients with
no placement of REBOA. Patients in the REBOA group also had higher rates of acute kidney
injury and lower leg amputations. There is a need for a concerted effort to clearly define
when and in which patient population REBOA has benefit.
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T rauma remains one of the leading causes of morbidityand mortality in the United States.1 More than 20% to40% of trauma deaths occurring after hospital admis-
sion are caused by massive hemorrhage that is potentially
preventable.2 Hemostatic resuscitation ensures normal he-
mostatic competence and resuscitation to improve prognosis
in suchpatients.3Temporaryhemostaticmeasures suchasaor-
tic occlusion have been used for more than 50 years.4 Endo-
luminal occlusion of the aorta with a balloon has been de-
scribed to occlude the blood flow distal to the diaphragm.5
Resuscitative endovascular balloon occlusion of the aorta
(REBOA) in traumawas first usedmore than 50years agodur-
ing resuscitativeefforts for injuredsoldiers in theKoreanWar4;
however, itwasnotmentioned in the emergencymedicine lit-
erature until 1986.6 The use of REBOA declined in the 1990s
andearly2000s.During thepastdecade,however,REBOAhas
gained the attention of trauma surgeons5,7-9 in both military
and civilian settings.
Trauma with a noncompressible torso hemorrhage re-
quires urgent hemorrhage control. Use of REBOA has been
showntoprovide circulatory support in suchpatientswithhy-
povolemia. In animal model studies, the use of REBOA could
temporize exsanguinating hemorrhage and was able to re-
store perfusion.9 Such therapy could be critical to definitive
hemorrhagecontrol.Anational,multi-institutional study from
Japan10has shownthatREBOAisassociatedwithahighermor-
tality,whileothers7,8havedemonstrated itsusefulness inclini-
cal settings toavoid life-threatinghemorrhage.However, in the
United States, extensive use of REBOA is limited because of
the lack of clinical and research evidence of its outcomes.Nu-
merous small single-center studies have analyzed the use of
REBOAintraumapatients.However, there isapaucityofmulti-
institutional data at anational level regarding the efficacy and
safetyofREBOA in theUnitedStates. Therefore, the aimofour
study was to evaluate the outcomes in trauma patients after
REBOA placement by using the national American College
of Surgeons Trauma Quality Improvement Program data set
(ACS-TQIP). We hypothesized that REBOA placement would
be associated with improved survival.
Methods
Study Design and Population
We performed a retrospective analysis of the 2015-2016 ACS-
TQIP database and identified all patients who received
REBOAwithin 1hour of admission. TheACS-TQIP is oneof the
largest databases of trauma patients in the United States: as
of2016,more than740hospitalswereparticipating in theACS-
TQIP. Trained personnel abstract more than 100 patient and
institutional variables. The University of Arizona Institu-
tional Review Board granted this study exemption from ap-
proval because theACS-TQIP contains only deidentifieddata.
Inclusion and Exclusion Criteria
We included all adult patients (≥18 years of age)who received
REBOA within 1 hour of presentation to the emergency de-
partment (ED). We excluded patients who were dead on
arrival, were transferred, had missing physiological para-
meters, orwhounderwent resuscitative thoracotomy.The fol-
lowing International Statistical Classification of Diseases and
RelatedHealthProblems,TenthRevisionprocedure codeswere
used to identify patients who underwent REBOA placement:
04L03DZ, 04L03DJ, 04L04DZ, and 02LW3DJ.
Data Points
We abstracted the following data points: demographics (age,
sex, race, and ethnicity), injury parameters (mechanism of
injury, injury severity score [ISS], and each body region ab-
breviated injury scale score [AIS]), prehospital and ED vital
signs (systolic bloodpressure [SBP], heart rate [HR], tempera-
ture, andGlasgowComa Scale [GCS] score), transfusion para-
meters (packedredbloodcells [PRBCs],platelets, and fresh fro-
zen plasma), hospital length of stay (LOS), in-hospital
complications, and mortality.
Patient Stratification
Patients were stratified into 2 cohorts based onwhether they
received the intervention: those who received REBOA
(theREBOAgroup) and thosewhodidnot receiveREBOA (the
no-REBOA group).
Outcomes
Our primary outcome measures were ED mortality, 24-hour
mortality, and mortality after 24 hours in both groups. Sec-
ondary outcomemeasures were transfusion requirements at
4 hours and 24 hours after injury, in-hospital complications
(deepvenous thrombosis, pulmonaryembolism, stroke,myo-
cardial infarction, extremity compartment syndrome, un-
planned return to the operating room, and lower limb ampu-
tation), hospital LOS, and intensive care unit LOS.
Missing Data Analysis
Missing data were treated as missing completely at random.
We performed multiple imputations using a missing value
analysis technique to account for themissing values. Formul-
tiple imputations, the original data set was analyzed for ran-
dommissing data points using the Little missing completely
Key Points
Question Is there a benefit of placement of resuscitative
endovascular balloon occlusion of the aorta for resuscitation of
severely injured trauma patients?
Findings In this case-control study that included 420 patients
(resuscitative endovascular balloon occlusion of the aorta, 140;
no resuscitative endovascular balloon occlusion of the aorta, 280),
the patients who received resuscitative endovascular balloon
occlusion of the aorta had significantly higher rates of acute kidney
injury and lower-limb amputation and higher mortality compared
with similarly injured patients who did not receive resuscitative
endovascular balloon occlusion of the aorta.
Meaning The use of resuscitative endovascular balloon occlusion
of the aorta in severely injured trauma patients may increase the
risk of complications andmortality.
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at random test. The Markov-Chain Monte Carlo method was
alsoused formultiple imputations.Thismethod refers toacol-
lection of methods for simulating random draws from non-
standard distributions.
Statistical Analysis
We performed propensity score matching. Patients who un-
derwent REBOA placement were matched with a similar co-
hort of patients who did not undergo REBOA placement in a
1:2 ratio fordemographics, vital signs (prehospital andEDSBP,
HR, and GCS score), mechanism of injury, ISS, each body re-
gionAIS, pelvic fractures (intact, incompletelydisrupted, and
completely disrupted pelvic ring), lower extremity vascular
injuries and fractures, and number and grades of intra-
abdominal solid organ injuries (liver, spleen, and kidney in-
juries). A logistic regressionmodelwasused to generate apro-
pensity score for each patient based on confounding factors.
Thepatients in the2groupswere thenmatchedbasedon their
propensity scores within 0.00001 of the estimated score.We
also used multivariate regression analysis to perform mul-
tiple subanalyses.
Descriptive statistics were performed. Continuous para-
metric data are reported as a mean and SD, continuous non-
parametric data as amedianand interquartile range (IQR), and
categorical data as aproportion.Toanalyze thedifferencesbe-
tween the 2 groups, a χ2 test was used for categorical vari-
ables, aMann-Whitneytest forcontinuousnonparametricdata,
and a t test for continuous parametric data. All P values were
from 2-sided tests and results were deemed statistically sig-
nificantatP < .05.All statistical analyseswereperformedusing
SPSS, version 24 (SPSS Inc).
Results
We analyzed 593818 trauma patients, of which 140 received
REBOA. The demographics and injury parameters of the pre-
matched data are summarized in Table 1. Patients who re-
Table 1. Prematch Demographics and Injury Parameters of the 2 Groups
Variables
Patients, No. (%)
P Value
No-REBOA Group
(n = 593 678)
REBOA Group
(n = 140)
Age, mean (SD), y 53 (21) 44 (20) <.001
Male sex 379 954 (64.0) 104 (74.3) .01
White race 436 353 (73.5) 89 (63.6) .003
Vital signs in ED
SBP, mean (SD), mm Hg 138.0 (27.0) 108.8 (32.7) <.001
HR, mean (SD), bpm 88.8 (20.0) 102.0 (30.0) <.001
GCS score, median (IQR) 15 (15-15) 14 (3-15) <.001
Injury parameters
Blunt MOI 565 181 (95.2) 129 (92.1) .11
ISS, median (IQR) 15 (9-17) 29 (18-38) <.001
h-AIS score, median (IQR) 0 (0-2) 0 (0-3) <.001
Pelvic fractures, total 46 307 (7.8) 74 (52.9)
<.001
With intact posterior arch 29 684 (5.0) 25 (17.9)
Incompletely disrupted posterior arch 13 061 (2.2) 33 (23.6)
Completely disrupted posterior arch 3562 (0.6) 16 (11.4)
Liver injuries, total 27 309 (4.6) 43 (30.7)
<.001Grades I-III 25 528 (4.3) 37 (26.4)
Grades IV-VI 1187 (0.2) 6 (4.3)
Splenic injuries, total 29 090 (4.9) 47 (33.6)
<.001Grades I-III 22 560 (3.8) 36 (25.7)
Grades IV-V 6530 (1.1) 11 (7.9)
Kidney injuries, total 14 248 (2.4) 22 (15.7)
<.001Grades I-III 11 280 (1.9) 19 (13.6)
Grades IV-V 2968 (0.5) 3 (2.1)
Lower limb fractures, total 39 776 (6.7) 41 (29.3)
<.001
Femur 31 465 (5.3) 27 (19.3)
Tibia 9499 (1.6) 20 (14.3)
Fibula 20 185 (3.4) 21 (15.0)
Vascular injuries, total 6530 (1.1) 41 (29.3)
<.001
Iliac 2375 (0.4) 29 (20.7)
Lower extremity 5937 (1.0) 11 (7.9)
Other 2375 (0.4) 38 (27.1)
Abbreviations: ED, emergency
department; GCS, Glasgow Coma
Scale; h-AIS, head Abbreviated Injury
Scale; HR, heart rate;
IQR, interquartile range; ISS, Injury
Severity Score; MOI, mechanism of
injury; REBOA, resuscitative
endovascular balloon occlusion of the
aorta; SBP, systolic blood pressure.
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ceived REBOA were more likely than those who did not re-
ceive REBOA to be younger (mean [SD] age, 44 [20] vs 53 [21]
years) nonwhite (51 [36.4%] vs 157 325 of 593 678 [26.5%];
P = .003), andmale (104[74.3%]vs379954of593678[64.0%];
P = .01). Patients who received REBOAweremore likely than
those who did not receive REBOA to have a lower mean (SD)
SBP (108.8 [32.7] vs 138.0 [27.0] mm Hg; P < .001), a higher
mean (SD) HR (102.0 [30.0] vs 88.8 [20.0] beats per minute;
P < .001), and a lower median GCS score (14 [IQR, 3-15] vs 15
[IQR, 15-15];P < .001)onadmission.Furthermore,patientswho
received REBOA had a higher median ISS (29 [IQR, 18-38] vs
15 [IQR, 9-17];P < .001) andamedianhigherhead-AIS (0 [IQR,
0-3] vs 0 [IQR, 0-2]; P < .001) than those who did not receive
REBOA.Regarding injuries,patientswhoreceivedREBOAwere
more likely than those who did not receive REBOA to have a
liver injury (43 [30.7%] vs 27 309of 593678 [4.6%];P < .001),
splenic injury (47 [33.6%] vs 29 090 of 593 678 [4.6%];
P < .001), or kidney injury (22 [15.7%] vs 14 248 of 593 678
[2.4%]; P < .001); a lower limb fracture (41 [29.3%] vs 39 776
of 593678 [6.7%]; P < .001); and vascular injuries (41 [29.3%]
vs 6530 of 593678 [1.1%]; P < .001).
Of the 593 818 trauma patients, 420 patients (the no-
REBOA group, 280 patients; the REBOA group, 140 patients)
werematched.AmongtheREBOAgroup, therewere36women
and 104 men, the mean (SD) age was 44 (20) years, the me-
dian ISSwas 29 (IQR, 18-38), and themechanismof injurywas
blunt injury in 129patients (92.1%). Thedemographics and in-
jury parameters of thematched cohort of trauma patients are
demonstrated inTable2. Therewasnodifferencebetween the
REBOAandno-REBOAgroups regardingmean(SD)age (44[20]
vs 43 [19] years; P = .88), sex (104 men [74.3%] vs 203 men
[72.5%];P = .76), race (89white patients [63.6%] vs 180white
patients [64.3%];P = .37),mean (SD) SBP (108.8 [32.7] vs 106.5
[28.7]mmHg;P = .65),mean (SD)HR(102 [30]vs 104[27]beats
perminute;P = .74),medianGCSscore (14 [IQR,3-15]vs 13 [IQR,
3-15];P = .88),mechanismof injury (blunt injury, 129 [92.1%]
vs 257 [91.8%]; P = .87), median ISS score (29 [IQR, 18-38] vs
28[IQR, 17-35];P = .91),medianheadAIS (0[IQR,0-3]vs0[IQR,
Table 2. Postmatch Demographics and Injury Parameters of the 2 Groups
Variables
Patients, No. (%)
P Value
No-REBOA Group
(n = 280)
REBOA Group
(n = 140)
Age, mean (SD), y 43 (19) 44 (20) .88
Male sex 203 (72.5) 104 (74.3) .76
White race 180 (64.3) 89 (63.6) .37
Vital signs in the ED
SBP, mean (SD), mm Hg 106.5 (28.7) 108.8 (32.7) .65
HR, mean (SD), bpm 104 (27) 102 (30) .74
GCS score, median (IQR) 13 (3-15) 14 (3-15) .88
Injury parameters
Blunt MOI 257 (91.8) 129 (92.1) .87
ISS, median (IQR) 28 (17-35) 29 (18-38) .91
h-AIS score, median (IQR) 0 (0-3) 0 (0-3) .98
Pelvic fractures, total 144 (51.4) 74 (52.9)
.65
With intact posterior arch 45 (16.1) 25 (17.9)
Incompletely disrupted posterior arch 68 (24.3) 33 (23.6)
Completely disrupted posterior arch 31 (11.1) 16 (11.4)
Liver injuries, total 89 (31.8) 43 (30.7)
.79Grades I-III 76 (27.1) 37 (26.4)
Grades IV-VI 13 (4.6) 6 (4.3)
Splenic injuries, total 90 (32.1) 47 (33.6)
.81Grades I-III 67 (23.9) 36 (25.7)
Grades IV-V 22 (7.9) 11 (7.9)
Kidney injuries, total 39 (13.9) 22 (15.7)
.82Grades I-III 35 (12.5) 19 (13.6)
Grades IV-V 5 (1.8) 3 (2.1)
Lower limb fractures, total 78 (27.9) 41 (29.3)
.69
Femur 48 (17.1) 27 (19.3)
Tibia 45 (16.1) 20 (14.3)
Fibula 32 (11.4) 21 (15.0)
Vascular injuries, total 76 (27.1) 41 (29.3)
.11
Iliac 53 (18.9) 29 (20.7)
Lower extremity 20 (7.1) 11 (7.9)
Other 11 (3.9) 38 (27.1)
Abbreviations: ED, emergency
department; GCS, Glasgow Coma
Scale; h-AIS, head Abbreviated Injury
Scale; HR, heart rate;
IQR, interquartile range; ISS, Injury
Severity Score; MOI, mechanism of
injury; REBOA, resuscitative
endovascular balloon occlusion of the
aorta; SBP, systolic blood pressure.
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0-3];P = .98),pelvic fracturesandtypeofpelvic fractures (total
pelvic fractures, 74 [52.9%] vs 144 [51.4%]; P = .65), liver in-
jury or severity of liver injury (total liver injuries, 43 [30.7%]
vs 89 [31.8%];P = .79), splenic injury or severity of splenic in-
jury (total splenic injuries, 47 [33.6%] vs 90 [32.1%]; P = .81),
kidney injury or severity of kidney injury (total kidney inju-
ries, 22 [15.7%] vs 39 [13.9%]; P = .82), lower limb fractures
(total fractures, 41 [29.3%] vs 78 [27.9%]; P = .69) (including
femur, tibia or fibula fractures), or vascular injuries (total in-
juries, 41 [29.3%] vs 76 [27.1%]; P = .11).
The overall EDmortality rate among all 420 patients was
2.1% (n = 9) (Table 3). The 24-hour mortality rate was 16.7%
(n = 70), and the in-hospitalmortality ratewas24.5%(n = 103).
The median 4-hour requirements among all 420 patients for
PRBCs were 7 U (IQR, 3-8 U), for platelets were 4 U (IQR, 3-8
U), and for plasmawas 3 U (IQR, 2-5 U), while themedian 24-
hour requirements among all 420 patients for PRBCswere 10
U (IQR, 4-20 U), for platelets were 8 U (IQR, 3-12 U), and for
plasmawas10U(IQR,6-20U).ThemedianhospitalLOSamong
all 420 patients was 9 days (IQR, 4-20 days), and the median
intensive care unit LOS was 6 days (IQR, 3-14 days). The me-
dian timefromEDpresentation to theplacementofREBOAwas
19 minutes (IQR, 14-29 minutes).
The primary and secondary outcome measures of the
analysis are presented in Table 3. Compared with patients in
theno-REBOAgroup,patients in theREBOAgrouphadahigher
24-hour mortality rate (37 [26.4%] vs 33 [11.8%]; P = .01),
as well as higher rates of acute kidney injury (15 [10.7%] vs
9 [3.2%]; P = .02) and amputation of a lower limb (5 [3.6%]
vs 2 [0.7%]; P = .04). However, there was no significant dif-
ference in EDmortality (4 [2.9%] vs 5 [1.8%]; P = .35),mortal-
ity after 24 hours (9 [6.4%] vs 15 [5.4%]; P = .21), rate of deep
venous thrombosis (6 [4.3%] vs 14 [5.0%]; P = .42), pulmo-
nary embolism (2 [1.4%] vs 5 [1.8%]; P = .28), myocardial in-
farction (0 vs 1 [0.4%]; P = .51), stroke (2 [1.4%] vs 3 [1.1%];
P = .37), and extremity compartment syndrome (1 [0.7%] vs 2
[0.7%]; P = .39) between the REBOA and no-REBOA groups.
Moreover, there was no difference between groups in 4-hour
or 24-hour blood transfusion requirements for PRBCs, plate-
lets, or plasma, andnodifference in hospital or intensive care
unitLOS.All thepatientswhosurvivedtheEDunderwenthem-
orrhage control interventionwith either angioembolizationor
exploratory laparotomy.However, therewasnodifferencebe-
tween theREBOAandno-REBOAgroups regarding the rate of
angioembolization (40 [28.6%] vs 85 [30.4%]; P = .18) or ex-
ploratory laparotomy (96 [68.6%]vs 190 [67.9%];P = .33). The
Table 3. Outcomes of Patients
Variable
Patients, No. (%)
P Value
No-REBOA Group
(n = 280)
REBOA Group
(n = 140)
4-h Transfusion, median (IQR), U
PRBCs 7 (3-9) 6 (3-8) .14
Platelets 4 (3-8) 4 (3-9) .13
Plasma 3 (2-6) 3 (2-5) .17
24-h Transfusion, median (IQR), U
PRBCs 10 (4-21) 9 (5-20) .21
Platelets 8 (3-12) 7 (3-13) .12
Plasma 10 (7-20) 9 (6-20) .11
Hemorrhage control intervention
Angioembolization 85 (30.4) 40 (28.6) .18
Time to angioembolization,
median (IQR), min
46 (31-69) 59 (39-78) .04
Laparotomy 190 (67.9) 96 (68.6) .33
Time to laparotomy, median (IQR), min 33 (26-62) 45 (35-69) .04
LOS, median (IQR), d
Hospital 10 (5-22) 8 (1-20) .21
ICU 6 (3-15) 5 (2-14) .19
Complications
Acute kidney injury 9 (3.2) 15 (10.7) .02
Amputation of lower limb 2 (0.7) 5 (3.6) .04
Deep venous thrombosis 14 (5.0) 6 (4.3) .42
Pulmonary embolism 5 (1.8) 2 (1.4) .28
Stroke 3 (1.1) 2 (1.4) .37
Myocardial infarction 1 (0.4) 0 .51
Extremity compartment syndrome 2 (0.7) 1 (0.7) .39
Overall mortality 53 (18.9) 50 (35.7) .01
Mortality in the ED 5 (1.8) 4 (2.9) .35
24-h Mortality 33 (11.8) 37 (26.4) .01
In-hospital mortality after 24 h 15 (5.4) 9 (6.4) .21
Abbreviations: ED, emergency
department; ICU, intensive care unit;
IQR, interquartile range; LOS, length
of stay; PRBCs, packed red blood
cells; REBOA, resuscitative
endovascular balloon occlusion of
the aorta.
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median time from ED presentation to angioembolization
(59 minutes [IQR, 39-78 minutes] vs 46 minutes [31-69 min-
utes]; P = .04) or exploratory laparotomy (45 minutes [IQR,
35-69 minutes] vs 33 minutes [IQR, 26-62 minutes]; P = .04)
was higher among patients who underwent REBOA place-
ment than thosewhodidnot undergoREBOAplacement. The
Figure demonstrates the survival functions for patients who
underwent REBOA placement vs those who did not undergo
REBOA placement.
Thedemographics and injury parameters of patientswho
underwent REBOA who survived (n = 90) vs those who died
(n = 50) are demonstrated in Table 4. Patients who survived
REBOAplacementweremore likely tohaveahighermean (SD)
SBP (114 [32]vs98 [31]mmHg;P = .006)andmedianGCSscore
(15 [IQR, 13-15] vs 3 [IQR, 3-13];P = .04), but a lowermean (SD)
HR (99.0 [27.0] vs 109.4 [25.0] beats perminute;P = .02),me-
dian ISS (27 [IQR, 17-34] vs 38 [26-50]; P = .043), andmedian
head AIS (0 [IQR, 0-2] vs 2 [IQR, 0-4]; P = .002). Moreover,
those who died were more likely to sustain liver injuries
(21 [42.0%] vs 22 [24.4%]; P = .04). Regarding blood product
requirements, patients who received REBOA and died were
more likely to receive PRBCs, platelets, and plasma at 4 hours
and 24 hours after injury.
We performed a subanalysis of patients based on SBP. In
a subset of patients with an SBP greater than 80 mm Hg,
REBOA placement was associated higher odds of mortality
(odds ratio, 4.67; 95% CI, 1.35-8.42; P = .03). Similarly, in the
subset of patients with an SBP less than 80 mm Hg, REBOA
placementwas independently associatedwith higher odds of
mortality (odds ratio, 2.51; 95%CI, 1.16-6.41; P = .03) onmul-
tivariate regression analysis. Another subanalysis was per-
formed for patients who underwent exploratory laparotomy
(n = 286:REBOAgroup, 96; no-REBOAgroup, 190); on regres-
sion analysis REBOA placement was associated with higher
mortality (odds ratio, 2.12; 95% CI, 1.67-3.84; P = .01).
Discussion
In our propensity-matched analysis from the ACS-TQIP data
bank, REBOAplacementwas associatedwith ahighermortal-
ity rate in severely injured trauma patients compared with
thosewhodidnot receiveREBOA.Moreover, patientswhoun-
derwent REBOA placement had higher rates of acute kidney
injury and lower limb amputation. On the contrary, therewas
nodifferencebetweengroups in requirements for bloodprod-
ucts at 4 hours and 24 hours after the injury.
Resuscitative endovascular balloonocclusionof the aorta
has emerged as a promising technique for hemostasis in se-
verely injured traumapatients.11 In animalmodels,REBOAhas
been demonstrated as a potential hemostatic measure in ex-
sanguinating animals that improves survival, increases blood
pressure, and improves brain oxygenation and carotid arte-
rial blood flow.12,13 This finding was followed up by a case se-
ries by Brenner et al14 in which 6 trauma patients underwent
REBOAplacement.Theyconcluded thatREBOA is feasible and
effective in preventing hemorrhage in patients with end-
stage shock. These findingswere then followed by a prospec-
tive observational study by DuBose et al,7 who analyzed 114
patients, ofwhich46underwentREBOAplacement.Theycon-
cluded thatREBOAhasemergedasaviableoption toopenaor-
tic occlusion in centers that have the capability of performing
REBOA placement.
We found that REBOA placement was associated with
highermortality andpoorer outcomes in traumapatients.Our
results are contrary to 2previously publishedprospective ob-
servational studies in the United States.7,15 These differences
canbeexplainedbyseveral limitations in those2studies.First,
both of those studies compared REBOA with open aortic oc-
clusion or resuscitative thoracotomy and the indications
for resuscitative thoracotomy are different than those for
REBOA. Thoracotomy in the emergency department is per-
formed in patientswho are experiencing cardiac arrest,while
REBOA is indicated for trauma patients who are hypotensive
and have a pelvic fracture or abdominal fluid detected on ini-
tial ultrasonographic scan in the traumabay.Moreover, those
studies did not have a true control group (ie, patientswhodid
not undergo REBOA placement and/or resuscitative thora-
cotomy). We have overcome this limitation by excluding the
patients who underwent thoracotomy in the ED and compar-
ing patients who underwent REBOA with similarly injured
trauma patients who did not undergo REBOA. Second, both
studies had small patient cohorts (Brenner et al,15 83 pa-
tients; andDuBose et al,7 46 patients), whichmay be an inad-
equate sample size with low power to draw a conclusion re-
garding the effectiveness of REBOA. On the other hand, we
included 140 patients in the REBOA groupmatchedwith 280
patients in the no-REBOA group, which is the largest patient
cohort toourknowledge forREBOAin theUnitedStates.Third,
there were significant differences regarding vital signs in the
Figure. Survival Curve Analysis
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ED and injury patterns between the 2 patient cohorts in the
studies by Brenner et al15 andDuBose et al.7 To overcome this
limitation, the patient cohorts in our analysis were matched
in terms of patient demographics, prehospital vital signs, ED
vitals, global injury severity, severity of injury in eachbody re-
gion,mechanismof injury, solid organ injuries, vascular inju-
ries, pelvic fractures, and lower extremity fractures. The re-
sults of our study are consistent with those of a previously
published study by Norii et al,10 who analyzed the safety and
efficacyofREBOA inseverely injured traumapatients fromthe
JapaneseNationalTraumaRegistryand reportedahighermor-
tality rate in the REBOA group after adjustment for the likeli-
hoodofREBOA treatment. The studybyNorii et al10 had some
limitations. They did not have data regarding the vital signs
at presentation or blood product transfusion. In our analysis,
we included thesedata points and therewasnodifference be-
tween the 2 patient cohorts regarding these variables. In ad-
dition, Norii et al10 did not analyze the complications of
REBOAdeploymentsuchasacutekidney injuryand lower limb
amputation.
The patients in the REBOA group in our study had a lon-
ger time to angioembolization or laparotomy, which might
be associated with a higher mortality rate. It is a well-
establishedfact in the traumaliterature thatdelayofeverymin-
ute in establishing definitive surgical control increases mor-
tality by 0.35%.16 In addition, although REBOAmay improve
cerebral andmyocardial perfusion, it decreasesblood flowdis-
tal to the point of occlusion and causes a state of ischemia in
the lower torso and lower extremities. This ischemia may in-
crease the overall inflammatory burden in the body andmay
cause a reperfusion injury when the occlusion of the aorta is
released.Multiple studies in traumahave reported that an in-
crease in inflammatory and reactive oxygen particles leads to
higher mortality.
Duration of occlusion of the aorta is critical once the pa-
tient survives the ED phase. Extended occlusion of the aorta
can cause ischemic damage to organs distal to the site of oc-
clusion secondary to low blood flow. Moreover, mechanical
damage to the aorta can cause aortic dissection or rupture, or
embolizationof a thrombus. In our analysis, patientswhoun-
derwent REBOA placement had higher rates of acute kidney
injury and amputation of a lower limb. Similar to our results,
Brenner et al15 reported a need for amputation and distal
embolism in patients who underwent REBOA. In addition,
Wasicek et al17 analyzed lower-limb complications in 31 pa-
tients and found that, among the 20 patients who received
REBOA at zone I, 15% developed lower extremity compart-
ment syndrome; they also found that a longer durationof aor-
Table 4. Subanalysis of PatientsWho Received REBOA
Variable
Patients, No. (%)
P Value
Survived
(n = 90)
Died
(n = 50)
Age, mean (SD), y 42 (19) 48.2 (19) .12
Male sex 57 (63.3) 32 (64.0) .20
Vital signs in the ED
SBP, mean (SD), mm Hg 114 (32) 98 (31) .006
HR, mean (SD), bpm 99.0 (27.0) 109.4 (25.0) .02
GCS score, median (IQR) 15 (13-15) 3 (3-13) .04
Injury parameters
Blunt MOI 82 (91.1) 47 (94.0) .54
ISS, median (IQR) 27 (17-34) 38 (26-50) .043
h-AIS, median (IQR) 0 (0-2) 2 (0-4) .002
Injuries
Pelvic fractures 48 (53.3) 26 (52.0) .14
Liver injuries 22 (24.4) 21 (42.0) .04
Splenic injuries 32 (35.6) 14 (28.0) .39
Kidney injuries 16 (17.8) 5 (10.0) .23
Lower limb fractures 29 (32.2) 11 (22.0) .65
Vascular injuries 26 (28.9) 14 (28.0) .11
Transfusion requirements, median (IQR), U
PRBCs
4 h 0 (0-5) 12 (7-19) <.001
24 h 1 (1-6) 14 (9-22) <.001
Platelets
4 h 0 (0-1) 2 (1-3) <.001
24 h 1 (0-2) 3 (2-6) <.001
Plasma
4 h 0 (0-3) 9 (4-15) <.001
24 h 1 (1-5) 13 (6-20) <.001
Abbreviations: ED, emergency
department; GCS, Glasgow Coma
Scale; h-AIS, head Abbreviated Injury
Scale; HR, heart rate;
IQR, interquartile range; ISS, Injury
Severity Score; MOI, mechanism of
injury; PRBCs, packed red blood cells;
REBOA, resuscitative endovascular
balloon occlusion of the aorta;
SBP, systolic blood pressure.
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tic occlusionat zone I is associatedwithhigher ratesof calf and
thigh fasciotomies.Regardingzoneofplacement,Tibbitset al18
found in a swine model that REBOA at zone I was indepen-
dently associatedwith ahigher burdenof ischemia andhigher
rates of reperfusion injury on deflation compared with con-
trol group. However, we could not obtain the duration of oc-
clusion nor the zone of occlusion, which is a limitation of our
study. Furthermore, Pieper et al19 published20years of expe-
rience with REBOA in France and demonstrated that REBOA
placementwas associatedwith high rates of vascular compli-
cations (including lower-limb ischemia and aortic dissec-
tion), acute renal failure, and rhabdomyolysis. Our study did
not demonstrate anydifference in the requirements for blood
products at 4 hours and 24 hours after injury in either group
of severely injured trauma patients. The median PRBC and
plasma requirements in the first 24hours in theREBOAgroup
is similar to that seen in the previously published literature.15
The ACS Committee on Trauma in collaboration with the
American College of Emergency Physicians has recently pub-
lished clinical guidelines regarding the safe use of REBOA.20
The American Association for the Surgery of Trauma, Aortic
Occlusion in Resuscitation for Trauma and Acute Care Sur-
gery (AORTA) group has already published 2 studies from 11
centers in theUnitedStates.However, they lackastandardpro-
tocol for REBOAplacement and an appropriate control group.
Most REBOA placement is at the discretion of the attending
trauma surgeon rather than in accordancewith a specific pro-
tocol. Currently, a REBOA device is available in 149 level 1
trauma centers,21 but the protocol varies for each institution
depending on resources as well as other factors.22 Because of
many reasons, including lack of funding and complex regula-
tions related topatient consent,muchof traumacare is driven
by the surgeon’s experience and retrospective studies. Resus-
citative endovascular balloon occlusion of the aorta has po-
tential application in the civilian andmilitary settings. In a ci-
vilian setting, REBOA may be beneficial in hemorrhaging
patientswith noncompressible torso hemorrhagewhodonot
have rapid access to a trauma center or the operating room for
definitive control of bleeding. In the military setting, REBOA
might be beneficial in the field, becauseREBOAcanbeplaced
in injured soldiers for a temporary control of lower torsoor ex-
tremity hemorrhage while waiting for transportation to a
traumaunit for definitive surgery.However, there is still a lack
of clinical data that adequately address the appropriate use of
REBOA and guide the absolute duration of full or partial aor-
tic occlusion. There needs to be a concerted effort to clearly
define when and in which patient population REBOA should
be used. Thus, further randomized clinical trials are required
to properly evaluate the indications of REBOA use in trauma
patients in accordance with specific well-defined protocols.
Currently, a randomized clinical trial is ongoing in the United
Kingdom, whichmight identify the specific subset of trauma
patients that might benefit from REBOA placement.23
Limitations
Our study has some limitations. Because of the retrospective
natureof thedatabase,wewerenot able toaccount forunmea-
sured confounders, including, but not limited to, the type and
sizeof thecatheterused, thezoneofplacement (ie, zone1, zone
2,orzone3), and thedurationofaorticocclusion.Moreover,we
could not determine the responsiveness of the patient to ini-
tial resuscitation before REBOA placement. This factor could
haveproduced thegreatestpotential bias in theselectionofpa-
tients for REBOAplacement.However, in our propensity score
matching,we tried tominimize selection bias bymatching the
demographics, injuryparameters,physiologicalparameters,and
intra-abdominal solidorgan injuries, alongwith thegrading. In
addition, because only small number of trauma centers have
used REBOA, the data may be skewed, which should be inter-
preted in similar contexts.Nonetheless, toourknowledge, this
is the first national study to compare the outcomes of REBOA
inseverely injuredtraumapatients.Ourstudyhas thestrengths
of a large sample sizederived frommultiple institutions across
the United States. In addition, the ACS-TQIP database is ad-
equately representativeof the traumapopulation in theUnited
States and its use is well established in trauma research.
Conclusions
Placement of REBOA in severely injured trauma patients was
associated with higher mortality compared with a similar
cohort of patients who did not undergo REBOA placement.
Resuscitative endovascular balloonocclusionof the aortawas
also associated with higher rates of acute kidney injury and
lower-leg amputations. There is a need for a concerted effort
to clearly define when and in which patient population
REBOA has benefit.
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Invited Commentary
The Need to Better Define theWho,What, andWhere
of Resuscitative Endovascular Balloon Occlusion of the Aorta
Gilbert R. Upchurch Jr, MD; R. Stephen Smith, MD, RDMS
In this issue of JAMA Surgery, Joseph et al1 examine the out-
comes in traumapatients after resuscitative endovascular bal-
loon occlusion of the aorta (REBOA) placement using 2 years
of theAmericanCollegeof SurgeonsTraumaQuality Improve-
ment Program (ACS-TQIP)
data set. The results demon-
strate that patients in a pro-
pensity-matchedcohort (140patients in theREBOAgroupand
280patients in theno-REBOAgroup)whounderwentREBOA
had a higher 24-hour mortality rate, acute kidney injury
rate, andamputation rate. Yet, therewasnodifference inmor-
tality in theemergencydepartmentormortality after 24hours
in thehospital. In addition, therewerenodifferences in trans-
fusion requirementsor intensivecareunit andhospital lengths
of stay. There was also no difference in survival based on
REBOAand theneed for further angioembolization or explor-
atory laparotomy procedures. The authors conclude by stat-
ing there is a significant “need for a concerted effort to clearly
define when and in which patient population REBOA has
a benefit.”
There clearly are somevaluablenuggetsofknowledge that
can be derived from this ACS-TQIP review of REBOA, despite
thesmall sample size.First—andweknowthis seemsobvious—
patients do not present to the emergency department follow-
ing the rulesofpropensitymatching. Patientspresentwithhy-
potensionandbleeding todeath. In addition,much important
individual patient information is simply not available from
the ACS-TQIP. For example, was a protocol used? What were
the indications for REBOAplacement?WasREBOAused early
or late in the course of treatment? Was the balloon deployed
in zone 1 or 2?Was REBOA placed by experienced surgeons at
high-volumecenters?WhichREBOAdevicewasused?Clearly,
REBOA will not raise the dead, but we should recognize this
fact after performing resuscitative thoracotomy for multiple
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